The Role of Electrostatics in the Function of Homologous Thioester Containing Proteins: Insights into the Evolution of the Complement C3d:Cr2 Interaction

被引：0
|
作者：
Kieslich, Chris A. [1 ]
Morikis, Dimitrios [1 ]
机构：
[1] Univ Calif Riverside, Riverside, CA 92521 USA
来源：
BIOPHYSICAL JOURNAL | 2012年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.bpj.2011.11.2539
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：463A / 463A
页数：1
相关论文
共 50 条
  • [41] IDENTIFICATION AND CHARACTERIZATION OF THE EPSTEIN-BARR VIRUS RECEPTOR ON HUMAN LYMPHOCYTES-B AND ITS RELATIONSHIP TO THE C3D COMPLEMENT RECEPTOR (CR-2)
    NEMEROW, GR
    WOLFERT, R
    MCNAUGHTON, ME
    COOPER, NR
    JOURNAL OF VIROLOGY, 1985, 55 (02) : 347 - 351
  • [42] Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: Activation of phosphatidylinositol 3-kinase via a CD19-independent pathway
    Bouillie, S
    Barel, M
    Frade, R
    JOURNAL OF IMMUNOLOGY, 1999, 162 (01): : 136 - 143
  • [43] EPSTEIN-BARR-VIRUS C3D RECEPTOR (CR2, CD21) ACTIVATED BY ITS EXTRACELLULAR LIGANDS REGULATES PP105 PHOSPHORYLATION THROUGH 2 DISTINCT PATHWAYS
    BOUILLIE, S
    BAREL, M
    DRANE, P
    CASSINAT, B
    BALBO, M
    HOLERS, VM
    FRADE, R
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2661 - 2667
  • [44] The solvent at antigen-binding site regulated C3d-CR2 interactions through the C-terminal tail of C3d at different ion strengths: insights from molecular dynamics simulation
    Zhang, Yan
    Guo, Jingjing
    Li, Lanlan
    Liu, Xuewei
    Yao, Xiaojun
    Liu, Huanxiang
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (10): : 2220 - 2231
  • [45] Treatment with a highly inhibitory monoclonal antibody directed to the C3d ligand binding site on human CR2/CD21 suppresses antigen-specific immune responses in vivo
    Kulik, Liudmila
    Hannan, Jonathan P.
    Huber, Brigitte T.
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2008, 45 (16) : 4111 - 4112
  • [46] Signal transduction pathways specifically triggered by the Epstein-Barr virus/C3d receptor (gp140, EBV/C3dR, CR2, CD21) on human B lymphocyte surface
    Barel, M
    Lottin, S
    Pouillot, S
    Frade, R
    FASEB JOURNAL, 2004, 18 (04): : A427 - A427
  • [47] Signal transduction pathways specifically triggered by the C3d receptor, which is also the EBV receptor (gp140, EBV/C3dR, CR2, CD21) on human B lymphocyte surface
    Barel, M
    Lottin, S
    Pouillot, S
    Frade, R
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 208 - 208
  • [48] CHARACTERIZATION OF A COMPLEMENT RECEPTOR-2 (CR2, CD21) LIGAND-BINDING SITE FOR C3 - AN INITIAL MODEL OF LIGAND INTERACTION WITH 2 LINKED SHORT CONSENSUS REPEAT MODULES
    MOLINA, H
    PERKINS, SJ
    GUTHRIDGE, J
    GORKA, J
    KINOSHITA, T
    HOLERS, VM
    JOURNAL OF IMMUNOLOGY, 1995, 154 (10): : 5426 - 5435
  • [49] Activation of the Epstein-Barr virus/C3d receptor (gp140, CR2, CD21, EBV/C3dR) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95 kDa nucleolin and its interaction with phosphatidylinositol 3-kinase
    Barel, M
    Le Romancer, M
    Frade, R
    FASEB JOURNAL, 2001, 15 (04): : A705 - A705
  • [50] Surface plasmon resonance (Biacore) and mAb inhibition analysis of human complement receptor (CR2/CD21) binding to complement C3d, EBV-gp350, low-affinity IgE receptor (CD23) and human interferon-α (IFN-α) reveal unique characteristics of binding but to a common interaction site
    Asokan, R
    Young, KA
    Hannan, JP
    Szakonyi, G
    Kraus, DM
    Kotzin, BL
    Cachia, PJ
    Chen, XS
    Gould, HJ
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 204 - 205
12345